Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Tue, 17th Mar 2020 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES PEARSON TO 'NEUTRAL' ('SELL') - PRICE TARGET 605 (505) PENCE

----------

GOLDMAN RAISES INFORMA TO 'NEUTRAL' ('SELL') - PRICE TARGET 729 (744) PENCE

----------

GOLDMAN CUTS RELX PRICE TARGET TO 2185.0 (2302.8) PENCE - 'BUY'

----------

GOLDMAN CUTS AUTO TRADER PRICE TARGET TO 653 (688) PENCE - 'BUY'

----------

GOLDMAN CUTS ITV PRICE TARGET TO 122 (147) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS WPP PRICE TARGET TO 900 (1045) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERGUSON PRICE TARGET TO 7100 (8100) PENCE - 'OVERWEIGHT'

----------

RBC CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 155 (200) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS LLOYDS BANKING PRICE TARGET TO 47 (66) PENCE - 'OUTPERFORM'

----------

RBC CUTS HSBC PRICE TARGET TO 440 (520) PENCE - 'UNDERPERFORM'

----------

RBC CUTS BARCLAYS PRICE TARGET TO 120 (170) PENCE - 'SECTOR PERFORM'

----------

HSBC RAISES STANDARD CHARTERED TO 'HOLD' ('REDUCE') - TARGET 480 (590) PENCE

----------

HSBC CUTS WPP PRICE TARGET TO 620 (1030) PENCE - 'HOLD'

----------

JPMORGAN CUTS DIAGEO PRICE TARGET TO 2150 (2800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COCA-COLA HBC PRICE TARGET TO 1980 (3000) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1550) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 8000 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS RECKITT BENCKISER PRICE TARGET TO 6500 (7700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES UNILEVER TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 3850 (4210) PENCE

----------

JPMORGAN CUTS WHITBREAD PRICE TARGET TO 2990 (3800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS INTERCONTINENTAL HOTELS TARGET TO 4150 (4600) P - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1920 (2040) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES JUST EAT TAKEAWAY.COM TO 'BUY' ('HOLD') - PRICE TARGET 8000 PENCE

----------

FTSE 250

----------

GOLDMAN CUTS ASCENTIAL TO 'BUY' ('CONVICTION BUY') - PRICE TARGET 373 (569) PENCE

----------

KEPLER CHEUVREUX RAISES TATE & LYLE TO 'BUY' ('HOLD') - TARGET 720 PENCE

----------

LIBERUM CUTS BALFOUR BEATTY PRICE TARGET TO 320 (400) PENCE - 'BUY'

----------

LIBERUM CUTS EQUINITI PRICE TARGET TO 265 (275) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS HAMMERSON PRICE TARGET TO 200 (300) PENCE - 'BUY'

----------

HSBC CUTS 4IMPRINT GROUP PRICE TARGET TO 2215 (2820) PENCE - 'HOLD'

----------

JPMORGAN CUTS BRITVIC PRICE TARGET TO 875 (1065) PENCE - 'OVERWEIGHT'

----------

GOLDMAN CUTS HUNTING PRICE TARGET TO 160 (398) PENCE - 'SELL'

----------

GOLDMAN CUTS JOHN WOOD PRICE TARGET TO 282 (467) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES PETROFAC TO 'BUY' ('NEUTRAL') - TARGET 316 (433) PENCE

----------

JPMORGAN CUTS SSP GROUP PRICE TARGET TO 730 (790) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 270 (375) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

GOLDMAN CUTS DAILY MAIL & GENERAL TRUST PRICE TARGET TO 632 (706) PENCE - 'SELL'

----------

LIBERUM CUTS KIER GROUP PRICE TARGET TO 115 (150) PENCE - 'BUY'

----------

BERENBERG CUTS BREEDON PRICE TARGET TO 105 (110) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
456789101112

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.